The luciferase reporter experiments were performed using the Dual-Luciferase Reporter Assays System (Promega Corporation, Madison, WI, USA). RPE cells were transfected with the pGL4 vector containing one of three fragments spanning nucleotides –500 bp to +67 bp from the LGALS1 transcription start site (promoter region; pGal), +450 bp to +1750 bp (enhancer region; pGal+AP-1), and AP-1 site (TGACTCA)-mutated enhancer region (pGalΔAP-1), as previously described.14 (link),15 (link) Mutation in two HRE sites in the LGALS1 promoter region (CACGC to CAAAC, positions at –441 bp to –437 bp and –427 bp to –423 bp)8 (link),12 (link) was synthesized and sequenced by Integrated DNA Technologies (Coralville, IA, USA), and subcloned into the pGL4 vector (pGalΔHRE). The pRL-CMV Renilla luciferase plasmid (Promega) was used as internal control. Cells were transfected with plasmid DNA using Lipofectamine LTX with Plus Reagent (Thermo Fisher Scientific) following the manufacturer's protocols.